An α-melanocyte-stimulating hormone analog, afamelanotide, is associated with reduced pain and improved quality of life in patients with erythropoietic protoporphyria, according to research published in the July 2 issue of the New England Journal of Medicine.
New classification of licensure for assistant physicians has been created, and public opinion is being sought by the Missouri State Board of Registration for the Healing Arts prior to filing these rules with the Secretary of State's Office and the Joint Committee on Administrative Rules.
MD Magazine recently reported on a study in JAMA Dermatology pointing to an alarming increase in the worldwide incidence of malignant melanoma (MM). The study, conducted in Denmark, shows that the incidence of MM has doubled during the past 25 years, despite targeted awareness campaigns and a focus within the dermatology community on early detection and treatment.
Patients with vitiligo have a choice of many treatment options, which run the gamut from applying make-up to depigmented areas, to light treatment, all the way up to surgery to move pigmented skin cells to affected areas. Yet, many patients elect not to treat the condition at all, despite the fact that the condition can be emotionally devastating and progressive.